Correlation Between Shattuck Labs and Anebulo Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Shattuck Labs and Anebulo Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Shattuck Labs and Anebulo Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Shattuck Labs and Anebulo Pharmaceuticals, you can compare the effects of market volatilities on Shattuck Labs and Anebulo Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Shattuck Labs with a short position of Anebulo Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Shattuck Labs and Anebulo Pharmaceuticals.
Diversification Opportunities for Shattuck Labs and Anebulo Pharmaceuticals
0.55 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Shattuck and Anebulo is 0.55. Overlapping area represents the amount of risk that can be diversified away by holding Shattuck Labs and Anebulo Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Anebulo Pharmaceuticals and Shattuck Labs is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Shattuck Labs are associated (or correlated) with Anebulo Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Anebulo Pharmaceuticals has no effect on the direction of Shattuck Labs i.e., Shattuck Labs and Anebulo Pharmaceuticals go up and down completely randomly.
Pair Corralation between Shattuck Labs and Anebulo Pharmaceuticals
Given the investment horizon of 90 days Shattuck Labs is expected to under-perform the Anebulo Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Shattuck Labs is 1.04 times less risky than Anebulo Pharmaceuticals. The stock trades about -0.15 of its potential returns per unit of risk. The Anebulo Pharmaceuticals is currently generating about 0.0 of returns per unit of risk over similar time horizon. If you would invest 181.00 in Anebulo Pharmaceuticals on September 2, 2024 and sell it today you would lose (37.00) from holding Anebulo Pharmaceuticals or give up 20.44% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Shattuck Labs vs. Anebulo Pharmaceuticals
Performance |
Timeline |
Shattuck Labs |
Anebulo Pharmaceuticals |
Shattuck Labs and Anebulo Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Shattuck Labs and Anebulo Pharmaceuticals
The main advantage of trading using opposite Shattuck Labs and Anebulo Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Shattuck Labs position performs unexpectedly, Anebulo Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Anebulo Pharmaceuticals will offset losses from the drop in Anebulo Pharmaceuticals' long position.Shattuck Labs vs. C4 Therapeutics | Shattuck Labs vs. Eliem Therapeutics | Shattuck Labs vs. Prelude Therapeutics | Shattuck Labs vs. Monte Rosa Therapeutics |
Anebulo Pharmaceuticals vs. Tff Pharmaceuticals | Anebulo Pharmaceuticals vs. Eliem Therapeutics | Anebulo Pharmaceuticals vs. Inhibrx | Anebulo Pharmaceuticals vs. Enliven Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Other Complementary Tools
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |